CTS NYSE: CTS reported third-quarter sales growth and record profitability, supported by higher revenue in its diversified end markets, favorable product mix and operational execution. The company also raised its full-year 2026 sales and adjusted earnings outlook and highlighted its recently completed acquisition of Millar, which expands its medical and industrial technology portfolio.

